Quantitative proteomic analysis of plasma in major mental disorders

ABSTRACT: Emerging high-throughput proteomic technologies have recently been considered as a powerful means of identifying substrates involved in mood disorders. We performed proteomic profiling using liquid chromatography-tandem mass spectrometry to identify dysregulated proteins in plasma samples of 44, 49, and 50 patients with major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia , respectively, in comparison to 51 healthy controls (HCs).

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell, Blood Plasma

DISEASE(S): Mental Depression

SUBMITTER: Dohyun Han  

LAB HEAD: Dohyun Han

PROVIDER: PXD028841 | Pride | 2022-02-16

REPOSITORIES: Pride